These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 26672094)
21. Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance. Muscelli E; Mari A; Natali A; Astiarraga BD; Camastra S; Frascerra S; Holst JJ; Ferrannini E Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1144-50. PubMed ID: 16478775 [TBL] [Abstract][Full Text] [Related]
22. Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids. Ohneda A; Parada E; Eisentraut AM; Unger RH J Clin Invest; 1968 Oct; 47(10):2305-22. PubMed ID: 5676526 [TBL] [Abstract][Full Text] [Related]
23. Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes. Steenberg VR; Jensen SM; Pedersen J; Madsen AN; Windeløv JA; Holst B; Quistorff B; Poulsen SS; Holst JJ Diabetologia; 2016 Feb; 59(2):363-70. PubMed ID: 26537124 [TBL] [Abstract][Full Text] [Related]
24. Relationship between insulin secretion and pancreas morphology in subjects with chronic pancreatitis. Zander E; Lorenz D; Ziegler B; Lippert H; Wolff H; Kostmann G; Dorn A; Besch W; Schulz B; Heinzmann B Horm Metab Res; 1984 Dec; 16 Suppl 1():149-54. PubMed ID: 6398255 [TBL] [Abstract][Full Text] [Related]
25. The role of aminogenic glucagon secretion in blood glucose homeostasis. Unger RH; Ohneda A; Aguilar-Parada E; Eisentraut AM J Clin Invest; 1969 May; 48(5):810-22. PubMed ID: 5780193 [TBL] [Abstract][Full Text] [Related]
27. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis. Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781 [TBL] [Abstract][Full Text] [Related]
28. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype. Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471 [TBL] [Abstract][Full Text] [Related]
29. Circulating glucagon after total pancreatectomy in man. Holst JJ; Pedersen JH; Baldissera F; Stadil F Diabetologia; 1983 Nov; 25(5):396-9. PubMed ID: 6653943 [TBL] [Abstract][Full Text] [Related]
30. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats. Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199 [TBL] [Abstract][Full Text] [Related]
31. Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects. Meier JJ; Deacon CF; Schmidt WE; Holst JJ; Nauck MA Diabetologia; 2007 Apr; 50(4):806-13. PubMed ID: 17334652 [TBL] [Abstract][Full Text] [Related]
32. Acute incretin response to oral glucose is associated with stimulation of gastric inhibitory polypeptide, not glucagon-like peptide in young subjects. Limb C; Tamborlane WV; Sherwin RS; Pederson R; Caprio S Pediatr Res; 1997 Mar; 41(3):364-7. PubMed ID: 9078536 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of glucagon secretion. Young A Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of hypoglycemic activity of total lignans from Fructus Arctii in the spontaneously diabetic Goto-Kakizaki rats. Xu Z; Ju J; Wang K; Gu C; Feng Y J Ethnopharmacol; 2014; 151(1):548-55. PubMed ID: 24269245 [TBL] [Abstract][Full Text] [Related]
35. Mosapride citrate, a 5-HT₄ receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men. Aoki K; Kamiyama H; Masuda K; Togashi Y; Terauchi Y Endocr J; 2013; 60(4):493-9. PubMed ID: 23257734 [TBL] [Abstract][Full Text] [Related]
36. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass. Nergård BJ; Lindqvist A; Gislason HG; Groop L; Ekelund M; Wierup N; Hedenbro JL Surg Obes Relat Dis; 2015; 11(6):1237-46. PubMed ID: 26143297 [TBL] [Abstract][Full Text] [Related]
37. Studies of glucagon secretion in pancreatectomized patients. Muller WA; Brennan MF; Tan MH; Aoki TT Diabetes; 1974 Jun; 23(6):512-6. PubMed ID: 4834290 [No Abstract] [Full Text] [Related]
39. The peculiar processing of glucagon and glucagon-related peptides in patients after pancreatectomy. Tanjoh K; Tomita R; Hayashi N Hepatogastroenterology; 2002; 49(45):825-32. PubMed ID: 12064000 [TBL] [Abstract][Full Text] [Related]
40. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release. Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]